SCHEMBL4359046

SCHEMBL4359046

COc1cc(O)c2c(=O)c(-c3cccc(O)c3)c[nH]c2c1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 6/20 0.80
SRC P12931 1/20 0.59
BRAF P15056 1/20 0.47
RET P07949 1/20 0.45
ALDH1A1 P00352 2/20 0.43
LMNA P02545 2/20 0.43
NPC1 O15118 3/20 0.43
CYP2C9 P11712 3/20 0.43
CYP2C19 P33261 3/20 0.43
MEN1 O00255 2/20 0.43
CYP2D6 P10635 2/20 0.43
NFKB1 P19838 2/20 0.43
RAB9A P51151 2/20 0.43
NFKB2 Q00653 2/20 0.43
KMT2A Q03164 2/20 0.43
RELA Q04206 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
CYP1A2 P05177 1/20 0.43
ALDH2 P05091 1/20 0.43
CYP3A4 P08684 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8574371 0.89 EGFR (1.00) EGFRSRCALDH1A1LMNANPC1
SCHEMBL4358045 0.89 EGFR (0.76) EGFRSRCALDH1A1LMNANPC1
SCHEMBL7256744 0.86 EGFR (0.70) EGFRSRCRETALDH1A1LMNA
SCHEMBL8578711 0.85 EGFR (0.78) EGFRSRCBRAFRETALDH1A1
SCHEMBL4361477 0.83 EGFR (0.73) EGFRSRCALDH1A1LMNANPC1
SCHEMBL7262295 0.75 ALDH1A1 (0.57) EGFRRETALDH1A1NPC1MEN1
SCHEMBL8572719 0.74 EGFR (0.73) EGFRSRCBRAFALDH1A1LMNA
SCHEMBL8574541 0.74 EGFR (1.00) EGFRSRCBRAFALDH1A1MEN1
SCHEMBL8576483 0.73 MEN1 (0.49) EGFRBRAFRETALDH1A1LMNA
SCHEMBL7256852 0.71 ALDH1A1 (0.56) EGFRALDH1A1NPC1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998017662-A1 PHENYL-SUBSTITUTED BICYCLIC HETEROCYCLYL DERIVATIVES AND THEIR USE NOVARTIS AG (CH) 1998-04-30 WO claimed
WO-2009070328-A1 MODULATORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) PATHWAY FOR USE IN THE TREATMENT OR PREVENTION OF SUBSTANCE ABUSE THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2009-06-04 WO disclosed
WO-1998017662-A1 PHENYL-SUBSTITUTED BICYCLIC HETEROCYCLYL DERIVATIVES AND THEIR USE NOVARTIS AG (CH) 1998-04-30 WO disclosed